Calendar of Events
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
1 event,
-
Kevin Outterson, Executive Director of CARB-X, will be speaking at the Harvard Chan School of Public Health. This presentation is sponsored by Harvard Antimicrobial Resistance (HAMR) a subgroup of the Harvard Infectious Diseases Consortium. For more information, visit harvardamr.com |
0 events,
|
0 events,
|
2 events,
Kevin Outterson, Executive Director of CARB-X, will be giving the keynote Address on November 7th, titled "A vision for a health antibiotic R&D ecosystem". Outterson will also be participating on a panel titled "Analyzing the potential impact of current commercial and “pull” initiatives" on November 7th. Karen Gallant, Deputy Executive Director of CARB-X, will be […]
-
Live Webinar: GARDP/REVIVE – Converting Gram-positive-only compounds into broad-spectrum antibiotics
Live Webinar: GARDP/REVIVE – Converting Gram-positive-only compounds into broad-spectrum antibiotics
This webinar by Paul Hergenrother (Department of Chemistry and the Institute for Genomic Biology University of Illinois, US) will detail his research group's efforts to understand compound accumulation in the Gram-negative ESKAPE pathogens. Emphasis will be placed on the practicality, actionability, and translatability of this information, specifically, the use of accumulation rules to convert high-value […] |
0 events,
|
0 events,
|
|
|
0 events,
|
1 event,
-
Presenters include Karen Gallant, Deputy Executive Director of CARB-X. Few technologies have the potential to disrupt and eliminate infectious disease and viral infections– but gene editing, CRISPR in particular, is a latent technology that could change biotech – and we’re just seeing the beginning of what effect it could have on the world. With scientific […] |
0 events,
|
1 event,
Kevin Outterson, Executive Director of CARB-X, is participating in a special panel discussion titled "When antibiotics fail: An international conversation about the worrisome evidence of impact and what can be done". During this session, a panel of international experts will discuss the findings from a new report by the Council of Canadian Academies and discuss […] |
0 events,
|
0 events,
|
|
|
1 event,
Presenters include Kevin Outterson, Executive Director of CARB-X, and Erin Duffy, CARB-X Chief of Research and Development. The FDA, IDSA, NIAID and Pew are co-sponsoring this workshop to focus on Enhancing the Clinical Trial Enterprise for Antibacterial Drug Development in the United States. This workshop will bring together a diverse array of subject matter experts […] |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
|
0 events,
|
1 event,
-
In this webinar our moderator Caroline Purslow (Nesta Challenges) will welcome three speakers. Till Bachmann (University of Edinburgh) will give an overview of recent advances in AMR diagnostics development. He will discuss: State of the art approaches for diagnosing infections and AMR Pipeline of promising tests Challenges of adoption Amrita Sukrity (SpotSense) will draw from […] |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|